Boyan Iliev, MD, EMBA, is currently the Business Value and Strategy Lead at Roche, where they leverage their extensive expertise in the biotechnology industry. With a solid background in people management, healthcare, and commercial effectiveness across various therapeutic areas, Boyan has held significant roles in companies such as GlaxoSmithKline, Pfizer, and Roche Pharmaceuticals. Boyan earned a Master of Medicine from Medical University Sofia and an EMBA from the American University in Bulgaria, reflecting their commitment to medical innovation and professional development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices